Operose Advisors’s ResMed RMD Stock Holding History

Operose Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-66	Closed	-$16.1K	–	595
2024 Q3	$16.1K	Hold	66	–	–	0.01%	424
2024 Q2	$12.6K	Hold	66	–	–	﹤0.01%	414
2024 Q1	$13.1K	Hold	66	–	–	﹤0.01%	450
2023 Q4	$11.4K	Sell	66 -149	-69%	-$22.9K	﹤0.01%	450
2023 Q3	$31.8K	Buy	+215	New	+$38.9K	0.01%	391

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Operose Advisors's RMD Position: Q4 2024 in Review

Operose Advisors sold out of ResMed (RMD) in Q4 2024, closing a stake of 66 shares — an estimated $16.1K sold.

Operose Advisors first reported a position in RMD in Q3 2023 and held it in 5 quarters. The position peaked at $31.8K in Q3 2023. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

Operose Advisors reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
Operose Advisors sold 66 ResMed shares in Q4 2024, an estimated $16.1K.
Operose Advisors first reported a position in ResMed in Q3 2023 and held it in 5 quarters.
Operose Advisors's ResMed position peaked at $31.8K in Q3 2023.
871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Operose Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.